Irreversible electroporation: state of the art
Open Access
- 1 April 2016
- journal article
- review article
- Published by Taylor & Francis Ltd in OncoTargets and Therapy
- Vol. ume 9, 2437-2446
- https://doi.org/10.2147/ott.s88086
Abstract
The field of focal ablative therapy for the treatment of cancer is characterized by abundance of thermal ablative techniques that provide a minimally invasive treatment option in selected tumors. However, the unselective destruction inflicted by thermal ablation modalities can result in damage to vital structures in the vicinity of the tumor. Furthermore, the efficacy of thermal ablation intensity can be impaired due to thermal sink caused by large blood vessels in the proximity of the tumor. Irreversible electroporation (IRE) is a novel ablation modality based on the principle of electroporation or electropermeabilization, in which electric pulses are used to create nanoscale defects in the cell membrane. In theory, IRE has the potential of overcoming the aforementioned limitations of thermal ablation techniques. This review provides a description of the principle of IRE, combined with an overview of in vivo research performed to date in the liver, pancreas, kidney, and prostate.Keywords
This publication has 59 references indexed in Scilit:
- The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic ReviewEuropean Urology, 2014
- Systematic Review and Meta-analysis of Studies Reporting Potency Rates After Robot-assisted Radical ProstatectomyEuropean Urology, 2012
- Systematic Review and Meta-analysis of Studies Reporting Urinary Continence Recovery After Robot-assisted Radical ProstatectomyEuropean Urology, 2012
- Electron Microscopic Demonstration and Evaluation of Irreversible Electroporation-Induced Nanopores on Hepatocyte MembranesJournal of Vascular and Interventional Radiology, 2012
- Management of hepatocellular carcinoma: An updateHepatology, 2011
- No surgical innovation without evaluation: the IDEAL recommendationsThe Lancet, 2009
- Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapiesHepatology, 2008
- Tumor Ablation with Irreversible ElectroporationPLOS ONE, 2007
- Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locationsHepatology, 2006
- Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulsesEuropean Journal of Cancer and Clinical Oncology, 1991